Medical Industry news

• Once-Weekly Oral Combo for HIV Maintains High Rates of Virologic Suppression

  22-12-2025 23:42 via medpagetoday.com
  (MedPage Today) -- A once-weekly oral combination of islatravir plus lenacapavir (Sunlenca) for HIV maintained similarly high rates of virologic suppression compared with standard daily oral treatment in an open-label phase II trial.
  In 104 virologically...
  
  Read more

• I've Survived Two School Shootings. I Implore You to Speak Up.

  22-12-2025 23:12 via medpagetoday.com
  (MedPage Today) -- If you've read the news recently, chances are you have seen the headlines about the mass shooting at Brown University that killed two of my fellow Brown students and injured nine others. You might have also seen me on the news...
  
  Read more

• More Americans Experience Troublesome Healthcare Costs Than Previously Thought

  22-12-2025 23:03 via medpagetoday.com
  (MedPage Today) -- A greater share of Americans than previously suggested experience burdensome healthcare costs, according to results from a nationally representative cohort study.
  Among more than 12,600 survey participants, 6.5% said they experienced...
  
  Read more

• Air Pollution Linked to Depression

  22-12-2025 22:07 via medpagetoday.com
  (MedPage Today) -- Long-term exposure to pollution from fine particulate matter and its major components--soil dust, sulfate, and elemental carbon--correlated with a greater risk of depression among older adults, a U.S. study showed.
  In...
  
  Read more

• Advertisement

• Nirsevimab Might Top Maternal Vax for Infants' RSV Protection

  22-12-2025 21:50 via medpagetoday.com
  (MedPage Today) -- Infants given the monoclonal antibody nirsevimab (Beyfortus) to provide passive immunity against respiratory syncytial virus (RSV) had a lower rate of related hospitalizations and severe outcomes than those whose mothers got...
  
  Read more

• Benzodiazepines Linked With Adverse Pregnancy Outcomes

  22-12-2025 21:25 via medpagetoday.com
  (MedPage Today) -- Use of benzodiazepines during pregnancy, particularly in the second trimester, was linked to some adverse pregnancy outcomes, a Taiwanese cohort study found.
  Among 454,477 pregnancies, benzodiazepine use was associated with...
  
  Read more

• FDA Opens Door to Quicker Approval of Osteoporosis Drugs

  22-12-2025 21:19 via medpagetoday.com
  (MedPage Today) -- The FDA gave the greenlight to use total hip bone mineral density (BMD) as a validated surrogate endpoint for clinical osteoporosis drug trials, the FDA announced on Friday.
  A BMD test measures calcium and other bone minerals...
  
  Read more

• CMS Funds 400 New Residency Slots

  22-12-2025 21:07 via medpagetoday.com
  (MedPage Today) -- The decision to fund 400 new medical residency positions at hospitals across the U.S. marks a meaningful--though limited--step toward addressing a looming physician shortage expected to worsen over the next decade, public...
  
  Read more

• Advertisement

• Half of Transgender, Gender Diverse Youth Report Suicidal Thoughts

  22-12-2025 20:55 via medpagetoday.com
  (MedPage Today) -- Nearly one in two transgender and gender diverse (TGD) youth reported suicidal ideation or self-injury, and one in four attempted suicide, a global meta-analysis showed.
  In a study of 131,429 TGD individuals ages 25 and younger...
  
  Read more

• Twins Joined at the Heart: Single Embryo Transfer Results in Unusual Case

  22-12-2025 19:17 via medpagetoday.com
  (MedPage Today) -- When a woman in her mid-40s underwent a single, genetically normal embryo transfer, clinicians expected--and counseled for--a singleton pregnancy.
  What followed instead was one of the rarest outcomes in assisted reproduction...
  
  Read more

• Study: Keep Hydroxychloroquine Doses High in Lupus

  22-12-2025 19:13 via medpagetoday.com
  (MedPage Today) -- Hydroxychloroquine (HCQ) doses of at least 400 mg/day provided better symptom relief for Taiwanese people with systemic lupus erythematosus (SLE) compared with lower doses, with the added benefit of less risk for cardiovascular...
  
  Read more

• Adding Tucatinib in First-Line Maintenance Boosts PFS in HER2-Positive Breast Cancer

  22-12-2025 18:56 via medpagetoday.com
  (MedPage Today) -- At the San Antonio Breast Cancer Symposium, investigators presented results from HER2CLIMB-05, a registrational trial evaluating the addition of tucatinib (Tukysa) to trastuzumab (Herceptin) and pertuzumab (Perjeta) maintenance...
  
  Read more

• Next-Gen Oral SERD Cuts Recurrence Risk in Early Breast Cancer

  22-12-2025 18:28 via medpagetoday.com
  (MedPage Today) -- At the San Antonio Breast Cancer Symposium, investigators reported phase III results showing that the oral selective estrogen-receptor degrader (SERD) giredestrant significantly reduced recurrence risk compared with standard...
  
  Read more

• Bispecific Antibody Effective in Untreated Follicular Lymphoma

  22-12-2025 18:08 via medpagetoday.com
  (MedPage Today) -- At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for patients with previously untreated follicular lymphoma with a high tumor burden.
  In this MedPage Today...
  
  Read more

• New Drug Approved for Hypertrophic Cardiomyopathy

  22-12-2025 18:06 via medpagetoday.com
  (MedPage Today) -- The FDA on Friday approved aficamten (Myqorzo) for symptomatic obstructive hypertrophic cardiomyopathy (HCM), drugmaker Cytokinetics announced.
  Aficamten is an allosteric and reversible inhibitor of cardiac myosin motor activity...
  
  Read more

• Trump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies

  22-12-2025 17:20 via medpagetoday.com
  (MedPage Today) -- President Trump announced on Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S.
  Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences...
  
  Read more

• Polatuzumab-Based Combination Continues to Impress in Real-World DLBCL Analyses

  22-12-2025 16:55 via medpagetoday.com
  (MedPage Today) -- At the recent American Society of Hematology annual meeting, real-world analyses examined how polatuzumab vedotin (Polivy) with rituximab, cyclophosphamide, doxorubicin, and prednisone (pola-R-CHP) is being adopted outside of...
  
  Read more

• Sniffing Out the Optimal Radiation Dose for Head and Neck Cancer

  22-12-2025 16:44 via medpagetoday.com
  (MedPage Today) -- Sense of smell in patients with head and neck cancer began to deteriorate at a radiation dose of 22 Gy and increased in a dose-related fashion, a small prospective study showed.
  Fewer than 20% of the 63 patients developed noticeable...
  
  Read more

• Fellow Nurses: Did You (or Will You) Go to Your Staff Christmas Party?

  22-12-2025 16:20 via medpagetoday.com
  (MedPage Today) -- It's the time of year again to deck the halls and get on your jingle jolly way, and with my holiday party date fast approaching I wondered--as I do every year--should I go? Did I really want to hang out with my coworkers...
  
  Read more

• Cheddar Cheese Recalled; Nick Reiner's Medication Change; How Safe Is U.S. Food?

  22-12-2025 15:28 via medpagetoday.com
  (MedPage Today) -- Note that some links may require registration or subscription.
  Some cheddar cheese products branded as Charlevoix Cheese Company Farm have been recalled due to potential Listeria contamination.
  Flu activity is high or very...
  
  Read more

Follow @Medical_IndusUK on Twitter!